Health News

FDA Approves Pomalyst for Advanced Multiple Myeloma
The US Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.
New Rx for Advanced Multiple Myeloma
Multiple myeloma is a blood cancer that affects nearly 22,000 Americans every year. It develops in mostly older people when plasma cells in the bone marrow grow out of control.
Cancer Wounds WTC Workers
When the World Trade Centers evaporated on 9/11, clouds of toxic chemicals were left in their wake. Researchers wanted to know the impact of these clouds on the health of rescue workers.
On The Job With Multiple Myeloma
Exposure to certain chemicals is thought to be a possible cause of a blood cancer called multiple myeloma. Researchers have honed in on this to see how occupation can affect risks.
Helping Cancer Cells Die
One of the genes that helps to keep cancer from ever forming is the p53 gene. It works by blocking cancer cells from killing themselves. When p53 is messed up in some way, cancer cells go to town and wreak havoc.
Leukemia and Workplace Chemicals
Benzene is a chemical that's used in a number of industrial processes. People who are exposed to this chemical in the workplace may have increased cancer risks.
Hitting Blood Cancer Early for Remission
Multiple myeloma is a cancer similar to leukemia, where immune system cells in the blood begin to multiply out of control.
With a Little Help From My Friends
Things always go a little easier when you've got a friend by your side. As it turns out, that's true on a cellular level as well.
Diabetes Linked to Blood Cancers
Doctors have to carefully watch their diabetes patients for other serious health problems like kidney disease and heart disease. Now, it seems doctors should keep an eye out for blood cancers as well.
Cancer Cart Before the Horse
The last few decades have seen an incredible growth in the number and kinds of drugs used to treat cancer, including entirely new classes of drugs outside traditional chemotherapy.